Recurrence after treatment for high-grade dysplasia: should we modify our post-treatment surveillance protocols?

Jonathan Carter1, Janie Sim, Russell Land

  • 1Sydney Gynaecologic Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. jocarter@mail.usyd.edu.au